期刊文献+

自乳化微乳对9-硝基喜树碱内酯型的保护效应 被引量:1

Protection Effect of Self-Emulsifying Microemulsion on 9-Nitrocamptothecin Lactone Form
下载PDF
导出
摘要 目的制备9-硝基喜树碱(9-nitrocamptothecin,9-NC)自乳化微乳(自微乳),并考察其对9-NC内酯型的体内外保护效应。方法以油酸乙酯为油相,Cremophor EL或Tween 80为乳化剂,PEG-400和无水乙醇为助乳化剂,制得2种9-NC自微乳。以9-NC溶液剂为对照,考察自微乳对9-NC内酯型结构的体内外保护效应。结果分别以Cremophor EL和Tween 80为乳化剂的自乳化油(油相-乳化剂-助乳化剂=20∶40∶40)在稀释倍数为20倍的水相中均可自发形成O/W型微乳液(9-NCME-C或9-NCME-T),粒径分别为(30.2±4.6)和(21.8±4.2)nm,Zeta电位分别为-(2.9±0.7)和-(8.1±0.9)mV,且具有良好的物理稳定性。与溶液剂(9-NCSol)相比,微乳能显著降低内酯型水解开环转变为羧酸盐型的速度,有利于提高体内9-NC活性结构(内酯型)的比例。大鼠静脉注射微乳(9-NCME-C和9-NCME-T)和溶液剂(9-NCSol)后血浆中内酯型9-NC的AUC0-∞分别为23072.24,20676.33和8954.97μg·min·L-1。结论自微乳对9-NC内酯型具有显著的体内外保护效应。 OBJECTIVE To prepare 9-nitrocamptothecin self-emulsifying microemulsion and investigate the protection effect of self-emulsifying microemulsion on 9-NC lactone form in vitro and in vivo. METHODS Two types of self-emulsifying microemulsion with Cremophor EL and Tween 80 as emulsifier respectively were prepared (SMEDDS-C and SMEDDS-T). Comparing with 9-NC solution, the protection effects of self-emulsifying microemulsion on 9-NC lactone were evaluated. RESULTS When the two kinds of SMEDDS were diluted with saline during the dilution ratio of 1 : 20, the diameters of microemulsions were ( 30. 2 ± 4. 6 ) and (21.8 ±4. 2) nm, and the potentials were - (2. 9 ± 0. 7) and - (8.1 ± 0. 3) mV for 9-NCME-C and 9-NCME-T, respectively. Microemulsion dramatically decreased the conversion rate of lactone form to carboxylate form and increased lactone form proportion. The AUC0-∞ of lactone form were 23 072. 24μg· min· L^-1for 9-NC SMEDDS-C, 20 676. 33 μg ·min· L^-1 for 9-NC SMEDDS-T and 8 954. 97 μg ·min · L^-1 for 9-NC solution after intravenous administration in rats. CONCLUSION The lactone form of 9-NC was significantly protected by self-emulsifying microemulsion.
出处 《中国药学杂志》 CAS CSCD 北大核心 2008年第16期1243-1247,共5页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30430706) 天然药物与仿生药物国家重点实验室985Ⅱ期研究基金
关键词 9-硝基喜树碱 自乳化微乳 内酯型 静脉注射 药动学 9-nitrocamptothecin self-emulsifying microemulsion lactone form intravenous injection pharmacokinetics
  • 相关文献

参考文献11

  • 1PANTAZIS P, KOZIELSKI A J, MENDOZA J T, et al. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice anddistinguish between non-tumorigenic and tumorigenic cells in vitro[J]. Int J Cancer, 1993,53(5) :863- 871.
  • 2FFSKIA P S, HERRA A, VERMORKEN J B, et al. Clinical phase Ⅱ study and pharmacological evaluation of mbitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue[J]. Eur J Cancer,2002,38(6) : 807-813.
  • 3BAKA S, RANSON M, LORIGAN P, et al. A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer [ J ]. Eur J Cancer, 2005,41 (11 ) :1547-1550.
  • 4ULUKAN H ,SWAAN P W. Camptothecins: A review of their chemotherapeutic potential [ J ]. Drugs ,2002,62 (14) : 2039-2057.
  • 5CAO Z ,HARRIS N , KOZIELSKI A , et al. Alkyl esters of camptothecin and 9-nitrocamptot-hecin : synthesis, in vitro pharmacokinetics , toxicity , and antitumor activity [ J ] . J Med Chem, 1998 ,41 (1) :31-37.
  • 6刘明星,王义明,罗国安.自微乳药物传递系统的研究进展[J].药学进展,2006,30(9):397-403. 被引量:17
  • 7张学农,唐丽华,阎雪莹,张强.紫杉醇自乳化微乳的制备及其在大鼠体内的药动学[J].中国新药与临床杂志,2005,24(4):294-298. 被引量:29
  • 8陈军,平其能,郭健新,丁明港.脂质体对9-硝基喜树碱内酯型和羧酸盐型体外平衡的影响[J].中国药科大学学报,2005,36(4):316-320. 被引量:18
  • 9CHEN J, PING Q N, GUO J X, et al. Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats[ J ]. Biopharm Drug Dispos, 2006, 27(2) :53-59.
  • 10BURKE T G, MI Z. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability [ J ]. J Med Chem, 1994 ,37 ( 1 ) :40 -46.

二级参考文献51

共引文献61

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部